Cancer therapy developer Lava Therapeutics has raised $18.6m in a round featuring Merck Research Laboratories unit MRL Ventures.

NUI Galway's Neurent Medical has been backed by government investors WDC and Enterprise Ireland as it continues development on its rhinitis treatment device.

American Family Ventures took part in the home equity investment platform's G20 Ventures-led series A round, which will fund product development.

Cancer therapy developer Lava Therapeutics has raised $18.6m in a round featuring Merck Research Laboratories unit MRL Ventures.

Capital One Growth Ventures is among the investors to have provided $14.6m in seed and series A funding for the data management platform.

The Flex-backed baby monitor developer has now raised a total of almost $30m after securing funding in a JVP-led series B round.

InnovAllianz, an investment subsidiary of Allianz, has contributed to a $15m funding round for 3D organ printing company Biomodex.

Asahi Glass has led a $12.5m round for digital additive printing technology developer Arevo that also featured Sumitomo Corporation of Americas.

ChromaCure has spun out of Université libre de Bruxelles with $19.6m in funding to commercialise treatments for cancer based on a new understanding on tumour metastasis.